NasdaqGM:MRUSBiotechs
Merus (MRUS) Forecasts 58.4% Revenue Growth, Ongoing Losses Challenge Bullish Narratives
Merus (MRUS) is projected to deliver standout revenue growth of 58.4% per year, far outpacing the US market average of 10.4% per year. However, the company remains unprofitable, with losses increasing at a 34.9% annual rate over the past five years and no improvement in net profit margins. Investors are watching closely, as persistent losses now set a high bar for optimism. At the same time, rapid top-line growth keeps the story in focus.
See our full analysis for Merus.
Next up, we will...